Identifying Heart, Lung, and Blood Disease-Causing Variants

by: TopGovernmentGrants Editorial Staff

The National Institutes of Health, otherwise known as NIH, is the agency operating within the United States Department of Health and Human Services that is fundamentally responsible for all of the country's biomedical and health-related research studies.

The programs and objectives of the NIH are tailored to contribute to the achievement of their agency mission, which is to "seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability."

In keeping with this mission, the National Institutes of Health has formed a partnership with the National Heart, Lung, and Blood Institute to establish a program that aims to Identify Heart, Lung, and Blood Disease-Causing Variants.

The Identifying Heart, Lung, and Blood Disease-Causing Variants Program aims to follow suit to research studies that intend to identify heart, lung, and blood disease-causing rare or lower frequency variants through the use of the extensive exome data that was discovered under the Recovery and Reinvestment Act of 2009.

The organizers of the program believe that this data will enable lung, heart and blood investigators, to focus on variants, genes, and pathways that could potentially lead them to a deeper and more thorough understanding of certain complex diseases.

  (continued...)

Identifying Heart, Lung, and Blood Disease-Causing Variants
  Page 2

About The Author The TopGovernmentGrants Editorial Staff maintains one the most comprehensive Websites offering information on government grants and federal government programs. The staff also provides resources to other Websites with information on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Effect of Physicochemical Properties of Ophthalmic Formulations on Ocular Bioavailability Program
In this capacity, the Food and Drug Administration has recently established the Effect of Physicochemical Properties of Ophthalmic Formulations on Ocular Bioavailability Program in an attempt to study the effects of various physicochemical properties of ophthalmic suspensions and emulsions on ocular bioavailability.

---

Biomedical and Behavioral Research Innovations to Ensure Equity in Maternal and Child Health
the National Institutes of Health has recently partnered with the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) to establish the Biomedical and Behavioral Research Innovations to Ensure Equity (BRITE) in Maternal and Child Health Grant Program.

---

Pilot Surveillance System for High Impact/Low Prevalence Congenital and Inherited Conditions Program
The Centers for Disease Control and Prevention has recently established the Pilot Surveillance System for High Impact/Low Prevalence Congenital and Inherited Conditions Program wherein it seeks to create and evaluate a surveillance system for congenital and inherited disease conditions.

---

Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research
The National Institutes of Health has formed a partnership with the National Cancer Institute(NCI) in an effort to establish the program entitled Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research.

---